Medicaid Bulletin

Update on temporary rates that are extending or being replaced with permanent, legislated increases.

Pharmacies can bill for FDA-approved in-home tests.

The Eligibility Portal is now available for registration and submission.

Effective with date of service Dec. 1, 2021, Medicaid and NC Health Choice cover ranibizumab injection for intravitreal use via ocular implant.

Effective with the date of service Jan. 1, 2022, CMS has added new HCPCS codes, deleted others and changed the description of some existing codes.

Provides an overview of the Department’s plans for promoting high-quality care through managed care and provides specific details to the measurement for the goals and objectives of the Department’s Quality Strategy.

Medicaid requires claims for CPT code 68761 be billed with one of four modifiers.

Certain immunocompromised children will qualify for third dose of Pfizer-BioN Tech Vaccine

Oral tablets covered for those in a home setting

Additional information to what was published in COVID-19 #210